2
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Squamous Cell Carcinoma of Head and Neck
20
Carcinoma, Non-Small-Cell Lung
20
Uterine Cervical Neoplasms
15
Oropharyngeal Neoplasms
14
Lung Neoplasms
14
Mouth Neoplasms
10
Laryngeal Neoplasms
10
Carcinoma
10
Urinary Bladder Neoplasms
8
Hypopharyngeal Neoplasms
8
Cholangiocarcinoma
8
Pancreatic Neoplasms
7
Ovarian Neoplasms
7
Nasopharyngeal Carcinoma
6
Mesothelioma, Malignant
6
Medulloblastoma
6
Gallbladder Neoplasms
6
Neuroblastoma
5
Ganglioneuroblastoma
5
Fallopian Tube Neoplasms
5
Lymphoid Interstitial Pneumonia
4
Vulvar Neoplasms
3
Urethral Neoplasms
3
Stomach Neoplasms
3
Small Cell Lung Carcinoma
3
Sarcoma
3
Carcinoma, Transitional Cell
3
Brenner Tumor
3
Adenocarcinoma of Lung
3
Vaginal Neoplasms
2
Interventions
Doxorubicin
25
Radiotherapy
16
Ifosfamide
14
Trabectedin
10
pazopanib
6
ribociclib
5
pembrolizumab
5
Specimen Handling
5
Magnetic Resonance Spectroscopy
5
Gemcitabine
5
Biopsy
5
palbociclib
4
Radiation
4
Docetaxel
4
Chemotherapy, Adjuvant
4
selinexor
3
liposomal doxorubicin
3
eribulin
3
abemaciclib
3
X-Rays
3
Vincristine
3
Neoadjuvant Therapy
3
Imatinib Mesylate
3
Filgrastim
3
Etoposide
3
Cyclophosphamide
3
toripalimab
2
temsirolimus
2
romidepsin
2
pegfilgrastim
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Liposarcoma
×
1,2-diaminocyclohexaneplatinum II citrate
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled